Literature DB >> 24804867

Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.

Yiting Geng1, Hui Wang, Changqing Lu, Qing Li, Bin Xu, Jingting Jiang, Changping Wu.   

Abstract

OBJECTIVE: Immune escape plays an important role in tumor progression. In the present study, the expression of B7-H1, B7-H4 and Foxp3 involved in immune escape in gastric carcinoma was investigated and the corresponding clinical significance was evaluated.
METHODS: Immunohistochemistry was used to detect the expression of B7-H1, B7-H4 and Foxp3 in 100 gastric cancer specimens, and 30 paracarcinoma tissues were used as the control.
RESULTS: Both B7-H1 and B7-H4 showed high expression levels in gastric cancer tissues (65.0 and 71.0 %, respectively), and the expressions of B7-H1 and B7-H4 were positively correlated with the depth of tumor invasion, lymph node metastasis and American Joint Committee on Cancer (AJCC) stage (P < 0.05). The number of Foxp3(+) Tregs was much higher in gastric cancer tissues than control tissues, which was positively correlated with lymph node metastasis (P < 0.05). Similarly, a positive correlation between B7-H1 or B7-H4 expression and the number of Foxp3(+) Tregs was observed. The median overall survival rate of patients with high expression of B7-H1, B7-H4 and Foxp3 was significantly poorer than that of patients with low expression of these proteins (P < 0.05). Cox regression multivariate analysis confirmed that lymph node metastasis, AJCC stage, and B7-H1 and Foxp3 overexpression were independent prognostic factors.
CONCLUSION: B7-H1, B7-H4 and Foxp3 were overexpressed in gastric cancer tissues. B7-H1 and Foxp3 are negative prognostic factors for patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24804867     DOI: 10.1007/s10147-014-0701-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  45 in total

Review 1.  Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses.

Authors:  Shengdian Wang; Lieping Chen
Journal:  Microbes Infect       Date:  2004-07       Impact factor: 2.700

2.  Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.

Authors:  Jingting Jiang; Yibei Zhu; Changping Wu; Yueping Shen; Wenxiang Wei; Lujun Chen; Xiao Zheng; Jing Sun; Binfeng Lu; Xueguang Zhang
Journal:  Cancer Immunol Immunother       Date:  2010-08-20       Impact factor: 6.968

Review 3.  Regulatory T-cell trafficking: from thymic development to tumor-induced immune suppression.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

4.  Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1.

Authors:  Xiaoming Lu; Jun Liu; Hang Li; Wei Li; Xuesong Wang; Jingwei Ma; Qiang Tong; Ke Wu; Guobin Wang
Journal:  J Surg Oncol       Date:  2011-06-21       Impact factor: 3.454

Review 5.  Regulatory T cells and cancer.

Authors:  Helen Y Wang; Rong-Fu Wang
Journal:  Curr Opin Immunol       Date:  2007-02-15       Impact factor: 7.486

6.  Overall survival and PD-L1 expression in metastasized malignant melanoma.

Authors:  Jules Gadiot; Anna I Hooijkaas; Andrew D M Kaiser; Harm van Tinteren; Hester van Boven; Christian Blank
Journal:  Cancer       Date:  2010-11-29       Impact factor: 6.860

Review 7.  The B7 family and cancer therapy: costimulation and coinhibition.

Authors:  Xingxing Zang; James P Allison
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

8.  Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance.

Authors:  Changping Wu; Yibei Zhu; Jingting Jiang; Jiemin Zhao; Xue-Guang Zhang; Ning Xu
Journal:  Acta Histochem       Date:  2006-03-13       Impact factor: 2.479

9.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

10.  Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage.

Authors:  R Houston Thompson; Xingxing Zang; Christine M Lohse; Bradley C Leibovich; Susan F Slovin; Victor E Reuter; John C Cheville; Michael L Blute; Paul Russo; Eugene D Kwon; James P Allison
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

View more
  54 in total

1.  Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer.

Authors:  Y Sunakawa; S Cao; N B Volz; M D Berger; D Yang; A Parekh; W Zhang; S Matsusaka; Y Ning; S Stremitzer; S Stintzing; A Sebio; S Okazaki; T Wakatsuki; M Azuma; M Watanabe; W Koizumi; A H Wu; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2016-05-31       Impact factor: 3.550

2.  Clinical retrospective study on the expression of the PD-L1 molecule in sporadic colorectal cancer and its correlation with K-ras gene mutations in Chinese patients.

Authors:  Jiasheng Xu; Wenpeng Zhao; Kaili Liao; Luxia Tu; Xiaozhen Jiang; Hua Dai; Yanqing Yu; Qiuying Xiong; Zhenfang Xiong
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  RICTOR expression in esophageal squamous cell carcinoma and its clinical significance.

Authors:  Wei-Jia Jiang; Ru-Xue Feng; Jia-Tao Liu; Lu-Lu Fan; Hua Wang; Guo-Ping Sun
Journal:  Med Oncol       Date:  2017-01-28       Impact factor: 3.064

4.  B7-H1 expression associates with tumor invasion and predicts patient's survival in human esophageal cancer.

Authors:  Lujun Chen; Haifeng Deng; Mingyang Lu; Bin Xu; Qi Wang; Jingting Jiang; Changping Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance.

Authors:  Xiaoxiao Li; Kai Ma; Shanai Song; Fangzhen Shen; Tao Kuang; Yingqian Zhu; Zimin Liu
Journal:  Clin Exp Med       Date:  2018-05-26       Impact factor: 3.984

6.  Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer.

Authors:  Kohei Yamashita; Masaaki Iwatsuki; Kazuto Harada; Kojiro Eto; Yukiharu Hiyoshi; Takatsugu Ishimoto; Yohei Nagai; Shiro Iwagami; Yuji Miyamoto; Naoya Yoshida; Yoshihiro Komohara; Jaffer A Ajani; Hideo Baba
Journal:  Gastric Cancer       Date:  2019-08-26       Impact factor: 7.370

7.  PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer.

Authors:  H K Angell; J Lee; K-M Kim; K Kim; S-T Kim; S H Park; W K Kang; A Sharpe; J Ogden; A Davenport; D R Hodgson; J C Barrett; E Kilgour
Journal:  Oncoimmunology       Date:  2018-12-10       Impact factor: 8.110

8.  B7-H3 expression associates with tumor invasion and patient's poor survival in human esophageal cancer.

Authors:  Lujun Chen; Jun Chen; Bin Xu; Qi Wang; Wei Zhou; Guangbo Zhang; Jing Sun; Liangrong Shi; Honglei Pei; Changping Wu; Jingting Jiang
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

9.  Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.

Authors:  Naoki Takahashi; Satoru Iwasa; Yusuke Sasaki; Hirokazu Shoji; Yoshitaka Honma; Atsuo Takashima; Natsuko Tsuda Okita; Ken Kato; Tetsuya Hamaguchi; Yasuhide Yamada
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-02       Impact factor: 4.553

10.  Comprehensive molecular profiling of the B7 family in gastrointestinal cancer.

Authors:  Qijie Zhao; Fuyan Hu; Zhangang Xiao; Mingxing Li; Xu Wu; Yueshui Zhao; Yuanlin Wu; Jianhua Yin; Ling Lin; Hanyu Zhang; Lingling Zhang; Chi Hin Cho; Jing Shen
Journal:  Cell Prolif       Date:  2018-07-12       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.